| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.4852 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5091 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5252 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5455 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5478 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5536 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5594 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.5905 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6006 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6034 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6190 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6191 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6282 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6293 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6504 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6546 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.6727 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7051 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7060 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7079 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7144 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7159 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7456 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7595 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7796 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7890 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.7971 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8007 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8014 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8121 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8141 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8271 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8505 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8633 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8635 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8652 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.8779 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9135 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9137 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9179 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9222 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9322 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9356 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9442 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9522 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9535 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9541 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9562 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9620 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9643 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9849 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9860 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 0.9980 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0020 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0126 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0241 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0279 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0351 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0391 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0468 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0609 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0609 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0658 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0828 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0851 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0921 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0964 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.0980 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1505 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1625 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1652 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1853 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1860 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1895 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.1972 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2081 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2090 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2115 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2274 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2407 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2717 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.2965 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3103 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3214 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3243 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3692 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3721 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.3957 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.4390 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.4511 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.5043 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.5045 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.6313 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.6956 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.7004 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.7592 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.7961 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 1.9672 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.0105 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.1111 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.1266 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.1536 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.3328 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.4375 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 2.8800 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 3-ureidopropionate | 4.7844 | Peak area | Diabetic Neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|